Larva Pharmaceutical Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 0.70 M
- Company Age 7 Year, 6 Months
- Last Filing with ROC 31 Mar 2024
- Satisfied Charges ₹ 1.50 M
- Revenue Growth -13.19%
- Profit Growth -47.36%
- Ebitda -16.37%
- Net Worth 3.27%
- Total Assets 14.04%
About Larva Pharmaceutical
Larva Pharmaceutical Private Limited (LPPL) is a Private Limited Indian Non-Government Company incorporated in India on 07 July 2017 (Seven years and six months 29 days old ). Its registered office is in Patna, Bihar, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.70 M.
The company has closed loans amounting to ₹1.50 M, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Alok Kaushal, Manish Kumar, and Vivek Mohan serve as directors at the Company.
Company Details
-
Location
Patna, Bihar, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U74999BR2017PTC035065
-
Company No.
035065
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
07 Jul 2017
-
Date of AGM
30 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Patna
Industry
Who are the key members and board of directors at Larva Pharmaceutical?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Alok Kaushal
|
Director | 07-Jul-2017 | Current |
|
Manish Kumar
|
Director | 05-Jun-2020 | Current |
|
Vivek Mohan
|
Director | 05-Jun-2020 | Current |
Financial Performance of Larva Pharmaceutical.
Larva Pharmaceutical Private Limited, for the financial year ended 2022, experienced significant reduction in revenue, with a 13.19% decrease. The company also saw a substantial fall in profitability, with a 47.36% decrease in profit. The company's net worth moved up by a moderate rise of 3.27%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Larva Pharmaceutical?
In 2020, Larva Pharmaceutical had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Audigo Hearing Solutions Private LimitedManish Kumar is a mutual person
-
Krishilok Agro Farmer Producer Company LimitedManish Kumar is a mutual person
-
Agrigo Life India Private Limited
Manish Kumar is a mutual person
Charges (Loans)
₹0
₹1.50 M
Charges Breakdown by Lending Institutions
- Others : 0.15 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 06 Feb 2018 | Others | ₹1.50 M | Satisfied |
How Many Employees Work at Larva Pharmaceutical?
Unlock and access historical data on people associated with Larva Pharmaceutical, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Larva Pharmaceutical, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Larva Pharmaceutical's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
